Literature DB >> 26497245

The tryptophan metabolite picolinic acid suppresses proliferation and metabolic activity of CD4+ T cells and inhibits c-Myc activation.

Johanna Prodinger1, Lisa J Loacker1, Ralf L J Schmidt1, Franz Ratzinger1, Georg Greiner1, Nadine Witzeneder1, Gregor Hoermann1, Sabrina Jutz1, Winfried F Pickl1, Peter Steinberger1, Rodrig Marculescu1, Klaus G Schmetterer2.   

Abstract

Tryptophan metabolites, including kynurenine, 3-hydroxyanthranilic acid, and picolinic acid, are key mediators of immunosuppression by cells expressing the tryptophan-catabolizing enzyme indoleamine2,3-dioxygenase. In this study, we assessed the influence of picolinic acid on cell viability and effector functions of CD4(+)T cells following in vitro activation with agonistic anti-CD3/anti-CD28 antibodies. In contrast to kynurenine and 3-hydroxyanthranilic acid, exposure of T cells with picolinic acid did not affect cell viability, whereas proliferation and metabolic activity were suppressed in a dose-dependent manner. On the other hand, cytokine secretion and up-regulation of cell surface activation markers were not or only weakly inhibited by picolinic acid. Picolinic acid exposure induced a state of deep anergy that could not be overcome by the addition of exogenous IL-2 and inhibited Th cell polarization. On the molecular level, important upstream signaling molecules, such as the MAPKs ERK and p38 and the mammalian target of rapamycin target protein S6 ribosomal protein, were not affected by picolinic acid. Likewise, NFAT, NF-κB, and AP-1 promoter activity in Jurkat T cells was not influenced by exposure to picolinic acid. Whereas transcriptional levels of v-myc avian myelocytomatosis viral oncogene homolog were not affected by picolinic acid, phosphorylation at Ser62 was strongly reduced in picolinic acid-exposed T cells following activation. In conclusion, picolinic acid mediates a unique immunosuppressive program in T cells, mainly inhibiting cell cycle and metabolic activity, while leaving other effector functions intact. These functional features are accompanied by reduced phosphorylation of v-myc avian myelocytomatosis viral oncogene homolog. It remains to be determined whether this effect is mediated by direct inhibition of ERK activity or whether indirect mechanisms apply. © Society for Leukocyte Biology.

Entities:  

Keywords:  anergy; immune tolerance; immunosuppression; indoleamine 2,3-dioxygenase

Mesh:

Substances:

Year:  2015        PMID: 26497245     DOI: 10.1189/jlb.3A0315-135R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  9 in total

1.  Identification and Characterization of a Novel pic Gene Cluster Responsible for Picolinic Acid Degradation in Alcaligenes faecalis JQ135.

Authors:  Jiguo Qiu; Lingling Zhao; Siqiong Xu; Qing Chen; Le Chen; Bin Liu; Qing Hong; Zhenmei Lu; Jian He
Journal:  J Bacteriol       Date:  2019-07-24       Impact factor: 3.490

2.  Novel 3,6-Dihydroxypicolinic Acid Decarboxylase-Mediated Picolinic Acid Catabolism in Alcaligenes faecalis JQ135.

Authors:  Jiguo Qiu; Yanting Zhang; Shigang Yao; Hao Ren; Meng Qian; Qing Hong; Zhenmei Lu; Jian He
Journal:  J Bacteriol       Date:  2019-03-13       Impact factor: 3.490

3.  PicR as a MarR Family Transcriptional Repressor Multiply Controls the Transcription of Picolinic Acid Degradation Gene Cluster pic in Alcaligenes faecalis JQ135.

Authors:  Siqiong Xu; Xiao Wang; Fuyin Zhang; Yinhu Jiang; Yanting Zhang; Minggen Cheng; Xin Yan; Qing Hong; Jian He; Jiguo Qiu
Journal:  Appl Environ Microbiol       Date:  2022-05-23       Impact factor: 5.005

4.  Prospective study of blood metabolites associated with colorectal cancer risk.

Authors:  Xiang Shu; Yong-Bing Xiang; Nathaniel Rothman; Danxia Yu; Hong-Lan Li; Gong Yang; Hui Cai; Xiao Ma; Qing Lan; Yu-Tang Gao; Wei Jia; Xiao-Ou Shu; Wei Zheng
Journal:  Int J Cancer       Date:  2018-03-14       Impact factor: 7.396

5.  Chloroquine inhibits human CD4+ T-cell activation by AP-1 signaling modulation.

Authors:  Ralf L J Schmidt; Sabrina Jutz; Katrin Goldhahn; Nadine Witzeneder; Marlene C Gerner; Doris Trapin; Georg Greiner; Gregor Hoermann; Guenter Steiner; Winfried F Pickl; Heinz Burgmann; Peter Steinberger; Franz Ratzinger; Klaus G Schmetterer
Journal:  Sci Rep       Date:  2017-02-07       Impact factor: 4.379

Review 6.  The Role of Indoleamine-2,3-Dioxygenase in Cancer Development, Diagnostics, and Therapy.

Authors:  Lilla Hornyák; Nikoletta Dobos; Gábor Koncz; Zsolt Karányi; Dénes Páll; Zoltán Szabó; Gábor Halmos; Lóránt Székvölgyi
Journal:  Front Immunol       Date:  2018-01-31       Impact factor: 7.561

Review 7.  Targeting Dietary and Microbial Tryptophan-Indole Metabolism as Therapeutic Approaches to Colon Cancer.

Authors:  Madhur Wyatt; K Leigh Greathouse
Journal:  Nutrients       Date:  2021-04-03       Impact factor: 5.717

Review 8.  Kynurenine Pathway Metabolites as Biomarkers in Alzheimer's Disease.

Authors:  Yuqing Liang; Shan Xie; Yanyun He; Manru Xu; Xi Qiao; Yue Zhu; Wenbin Wu
Journal:  Dis Markers       Date:  2022-01-19       Impact factor: 3.434

9.  Comprehensive assessment of multiple tryptophan metabolites as potential biomarkers for immune checkpoint inhibitors in patients with non-small cell lung cancer.

Authors:  M Karayama; J Masuda; K Mori; H Yasui; H Hozumi; Y Suzuki; K Furuhashi; T Fujisawa; N Enomoto; Y Nakamura; N Inui; T Suda; M Maekawa; H Sugimura; A Takada
Journal:  Clin Transl Oncol       Date:  2020-06-12       Impact factor: 3.405

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.